MSN Ecuador represents a strong commitment to innovation and continuous improvement in the healthcare sector. Backed by MSN’s global strength of 19 API manufacturing plants, 8 finished dosage facilities, and an integrated Research & Development Center, we deliver high-quality, safe, reliable, and affordable pharmaceutical solutions.

Our focus is on enhancing patient access, improving therapeutic adherence, and ensuring safety through awareness initiatives, pharmacovigilance systems, and strong partnerships with patient groups.

With a research-driven approach, MSN Ecuador supports stakeholders in successfully launching quality pharmaceutical products while building long-term commercial synergies and strategic collaborations.

Future Focus

Our vision is to strengthen MSN Labs’ presence in Ecuador by expanding our portfolio, enhancing commercial synergies, and exploring strategic licensing partnerships.

We aim to continue supporting stakeholders with innovative, research-backed pharmaceutical solutions.

Team MSN Ecuador

Key Therapeutic Areas

Oncology
Cardiovascular
Anti-Diabetic Treatments
Central Nervous System (CNS)
Urology

Address

MSN Labs Ecuador SA
Guayas E3-112 y Amazonas,
Edificio Torre Centre,
Piso 5, Oficina 501

Adverse Event Reporting

regulatory.ecuador@msnlabs.com